(11-104) Long-Acting, High-Impact: A Cost-Utilization Review of Initiating a Long-Acting Injectable Anti-Psychotic Formulary in the Inpatient Setting

Wednesday, December 10, 2025

12:30 PM - 1:30 PM

Location: Bayside A, Level 1

Residency Program: St. Luke's Hospital of Duluth
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Minnesota

Co-Author(s): Joy Bittner

Primary Author(s)